About Biopeptide
Biopeptide is a Healthcare company based in San Diego (United States) founded in 1999. Custom peptides are designed and synthesized using t-BocFmoc technologies. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Proteomics. Its competitors include Nautilus Biotechnology, ProteinSimple and Somalogic; 3 of its 3 listed competitors have raised funding.
Company details
Biopeptide was founded in 1999 in San Diego, United States, within the biotechnology sector. Operations focus on the design, synthesis, and production of custom peptides through t-BocFmoc solid phase and solution phase methods. Services include the creation of specialized peptides such as Beta-amyloid and Ghrelin, supporting research and development needs in peptide-based applications.
- Headquarters San Diego, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biopeptide.com
- Social LinkedIn
- Latest Funding Round$600K (USD), Grant
Sep 2011
- Investors
Funding Insights of Biopeptide
- Total Rounds 1
- Last Round Grant — $600,000
- First Round $600,000
(Sep 2011)
- Investors Count 1
All 1 funding rounds of Biopeptide with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2011 | $600,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Biopeptide
Biopeptide has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | hhs.gov |
Investor details for Biopeptide
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biopeptide
2 dated milestones of Biopeptide across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Biopeptide is founded.
- Funding First funding round of $600K.
Competitors of Biopeptide
Biopeptide has 3 listed competitors in our database, 3 of them funded. They include Nautilus Biotechnology, ProteinSimple and Somalogic.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nautilus.bio | 2016 | Seattle, United States | $103.26M | 134 | A proteomics platform is developed for analyzing the human proteome. | |
| proteinsimple.com | 2004 | San Jose, United States | $114.29M | 157 | Provider tools to help researchers with protein analysis | |
| somalogic.com | 1999 | Boulder, United States | $663.99M | 319 | Protein-based assays are developed for life science research. |
Detailed competitors of Biopeptide
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biopeptide
The website of Biopeptide (biopeptide.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 31.4% vs previous month
Websites whose visitors overlap most with Biopeptide. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| quantabiodesign.com | 100% | View details | |||
| blueheronbio.com | 81% | 1.9K | #9,050,195 | View details | |
| beaconindia.com | 80% | View details | |||
| sequenom.com | 75% | View details | |||
| biosearchtech.com | 67% | 52K | #598,672 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Biopeptide
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Biopeptide (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biopeptide
Biopeptide was founded in 1999 and raised its 1st funding round 12 years after it was founded.
Biopeptide is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Biopeptide was founded in 1999 in San Diego, United States, within the biotechnology sector. Operations focus on the design, synthesis, and production of custom peptides through t-BocFmoc solid phase and solution phase methods. Services include the creation of specialized peptides such as Beta-amyloid and Ghrelin, supporting research and development needs in peptide-based applications.
Biopeptide's top competitors include Somalogic, Nautilus Biotechnology and ProteinSimple.
Biopeptide has 1 investor. Key investors include HHS.